These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37146728)

  • 1. Practice Competition and Treatment of Newly Diagnosed Prostate Cancer.
    Maganty A; Hollenbeck BK; Kaufman SR; Oerline MK; Lai LY; Caram MEV; Shahinian VB
    Urology; 2023 Jul; 177():95-102. PubMed ID: 37146728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly.
    Hollenbeck BK; Kaufman SR; Yan P; Herrel LA; Borza T; Schroeck FR; Jacobs BL; Skolarus TA; Shahinian VB
    Eur Urol; 2018 Apr; 73(4):491-498. PubMed ID: 28823605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care delivery system contributions to management of newly diagnosed prostate cancer.
    Krampe N; Kaufman SR; Oerline MK; Hill D; Caram MEV; Shahinian VB; Hollenbeck BK; Maganty A
    Cancer Med; 2023 Aug; 12(16):17346-17355. PubMed ID: 37475511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between urology practice use of multiparametric MRI and genomic testing and treatment of men with newly diagnosed prostate cancer.
    Faraj KS; Kaufman SR; Herrel LA; Oerline MK; Maganty A; Shahinian VB; Hollenbeck BK
    Urol Oncol; 2023 Oct; 41(10):430.e17-430.e23. PubMed ID: 37580226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.
    Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline MK; Caram MEV; Shahinian VB; Hollenbeck BK
    Cancer; 2024 May; 130(9):1609-1617. PubMed ID: 38146764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urologist Practice Structure and Spending for Prostate Cancer Care.
    Modi PK; Herrel LA; Kaufman SR; Yan P; Borza T; Skolarus TA; Schroeck FR; Hollenbeck BK; Shahinian VB
    Urology; 2019 Aug; 130():65-71. PubMed ID: 31029672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer.
    Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline M; Caram MEV; Shahinian VB; Hollenbeck BK
    Cancer Med; 2023 Dec; 12(24):22325-22332. PubMed ID: 38100144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities.
    Agochukwu-Mmonu N; Qin Y; Kaufman S; Oerline M; Vince R; Makarov D; Caram MV; Chapman C; Ravenell J; Hollenbeck BK; Skolarus TA
    JCO Oncol Pract; 2023 May; 19(5):e763-e772. PubMed ID: 36657098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Practice Structure on Urologists' Treatment of Men With Low-Risk Prostate Cancer.
    Mitchell JM; Gresenz CR
    Med Care; 2022 Sep; 60(9):665-672. PubMed ID: 35880758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations.
    Modi PK; Kaufman SR; Borza T; Yan P; Miller DC; Skolarus TA; Hollingsworth JM; Norton EC; Shahinian VB; Hollenbeck BK
    Cancer; 2018 Aug; 124(16):3364-3371. PubMed ID: 29905943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Trends in Management of Newly Diagnosed Prostate Cancer.
    Maganty A; Kaufman SR; Oerline MK; Lai LY; Caram MEV; Shahinian VB; Hollenbeck BK
    Clin Genitourin Cancer; 2024 Apr; 22(2):10-17. PubMed ID: 37468340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees.
    Marchetti KA; Oerline M; Hollenbeck BK; Kaufman SR; Skolarus TA; Shahinian VB; Caram MEV; Modi PK
    Urology; 2021 Sep; 155():77-82. PubMed ID: 33610652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of advanced treatment technologies among men at low risk of dying from prostate cancer.
    Jacobs BL; Zhang Y; Schroeck FR; Skolarus TA; Wei JT; Montie JE; Gilbert SM; Strope SA; Dunn RL; Miller DC; Hollenbeck BK
    JAMA; 2013 Jun; 309(24):2587-95. PubMed ID: 23800935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Hospital Market Competition with Outcomes of Complex Cancer Surgery.
    Munir MM; Woldesenbet S; Endo Y; Dillhoff M; Tsai S; Pawlik TM
    Ann Surg Oncol; 2024 Jul; 31(7):4371-4380. PubMed ID: 38634960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Dispensing Among Urology Practices and the Use of Abiraterone or Enzalutamide for Men With Advanced Prostate Cancer.
    Lai LY; Kaufman SR; Oerline MK; Caram MEV; Maganty A; Hollenbeck BK; Shahinian VB
    JNCI Cancer Spectr; 2022 Mar; 6(2):. PubMed ID: 35603854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of evolving delivery system reforms for prostate cancer care.
    Hollenbeck BK; Bierlein MJ; Kaufman SR; Herrel L; Skolarus TA; Miller DC; Shahinian VB
    Am J Manag Care; 2016 Sep; 22(9):569-75. PubMed ID: 27662220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer.
    Lu-Yao GL; Albertsen PC; Moore DF; Lin Y; DiPaola RS; Yao SL
    Eur Urol; 2015 Nov; 68(5):805-11. PubMed ID: 25800944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice-Level Adoption of Conservative Management for Prostate Cancer.
    Modi PK; Kaufman SR; Herrel LA; Dupree JM; Luckenbaugh AN; Skolarus TA; Hollenbeck BK; Shahinian VB
    J Oncol Pract; 2019 Oct; 15(10):e863-e869. PubMed ID: 31509481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sharp Decline In Prostate Cancer Treatment Among Men In The General Population, But Not Among Diagnosed Men.
    Borza T; Kaufman SR; Shahinian VB; Yan P; Miller DC; Skolarus TA; Hollenbeck BK
    Health Aff (Millwood); 2017 Jan; 36(1):108-115. PubMed ID: 28069853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer.
    Hill D; Kaufman SR; Oerline MK; Faraj K; Caram MEV; Shahinian VB; Hollenbeck BK; Maganty A
    JNCI Cancer Spectr; 2023 Jul; 7(5):. PubMed ID: 37643638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.